Cargando…

Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies

The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Blarcom, Thomas, Lindquist, Kevin, Melton, Zea, Cheung, Wai Ling, Wagstrom, Chris, McDonough, Dan, Valle Oseguera, Cendy, Ding, Sheng, Rossi, Andrea, Potluri, Shobha, Sundar, Purnima, Pitts, Steven, Sirota, Marina, Galindo Casas, Meri, Yan, Yu, Jones, Jeffrey, Roe-Zurz, Zygy, Srivatsa Srinivasan, Surabhi, Zhai, Wenwu, Pons, Jaume, Rajpal, Arvind, Chaparro-Riggers, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825193/
https://www.ncbi.nlm.nih.gov/pubmed/29227213
http://dx.doi.org/10.1080/19420862.2017.1406570
_version_ 1783302162837667840
author Van Blarcom, Thomas
Lindquist, Kevin
Melton, Zea
Cheung, Wai Ling
Wagstrom, Chris
McDonough, Dan
Valle Oseguera, Cendy
Ding, Sheng
Rossi, Andrea
Potluri, Shobha
Sundar, Purnima
Pitts, Steven
Sirota, Marina
Galindo Casas, Meri
Yan, Yu
Jones, Jeffrey
Roe-Zurz, Zygy
Srivatsa Srinivasan, Surabhi
Zhai, Wenwu
Pons, Jaume
Rajpal, Arvind
Chaparro-Riggers, Javier
author_facet Van Blarcom, Thomas
Lindquist, Kevin
Melton, Zea
Cheung, Wai Ling
Wagstrom, Chris
McDonough, Dan
Valle Oseguera, Cendy
Ding, Sheng
Rossi, Andrea
Potluri, Shobha
Sundar, Purnima
Pitts, Steven
Sirota, Marina
Galindo Casas, Meri
Yan, Yu
Jones, Jeffrey
Roe-Zurz, Zygy
Srivatsa Srinivasan, Surabhi
Zhai, Wenwu
Pons, Jaume
Rajpal, Arvind
Chaparro-Riggers, Javier
author_sort Van Blarcom, Thomas
collection PubMed
description The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can be combined with a minimal set of Fc mutations to drive heavy chain heterodimerization in order to address these challenges. However, the facile generation of common light chain antibodies with properties similar to traditional monoclonal antibodies has not been demonstrated and they have only been used sparingly. Here, we describe the design of a synthetic human antibody library based on common light chains to generate antibodies with biochemical and biophysical properties that are indistinguishable to traditional therapeutic monoclonal antibodies. We used this library to generate diverse panels of well-behaved, high affinity antibodies toward a variety of epitopes across multiple antigens, including mouse 4-1BB, a therapeutically important T cell costimulatory receptor. Over 200 BsIgG toward 4-1BB were generated using an automated purification method we developed that enables milligram-scale production of BsIgG. This approach allowed us to identify antibodies with a wide range of agonistic activity that are being used to further investigate the therapeutic potential of antibodies targeting one or more epitopes of 4-1BB.
format Online
Article
Text
id pubmed-5825193
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-58251932018-03-01 Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies Van Blarcom, Thomas Lindquist, Kevin Melton, Zea Cheung, Wai Ling Wagstrom, Chris McDonough, Dan Valle Oseguera, Cendy Ding, Sheng Rossi, Andrea Potluri, Shobha Sundar, Purnima Pitts, Steven Sirota, Marina Galindo Casas, Meri Yan, Yu Jones, Jeffrey Roe-Zurz, Zygy Srivatsa Srinivasan, Surabhi Zhai, Wenwu Pons, Jaume Rajpal, Arvind Chaparro-Riggers, Javier MAbs Report The commercial success of bispecific antibodies generally has been hindered by the complexities associated with generating appropriate molecules for both research scale and large scale manufacturing purposes. Bispecific IgG (BsIgG) based on two antibodies that use an identical common light chain can be combined with a minimal set of Fc mutations to drive heavy chain heterodimerization in order to address these challenges. However, the facile generation of common light chain antibodies with properties similar to traditional monoclonal antibodies has not been demonstrated and they have only been used sparingly. Here, we describe the design of a synthetic human antibody library based on common light chains to generate antibodies with biochemical and biophysical properties that are indistinguishable to traditional therapeutic monoclonal antibodies. We used this library to generate diverse panels of well-behaved, high affinity antibodies toward a variety of epitopes across multiple antigens, including mouse 4-1BB, a therapeutically important T cell costimulatory receptor. Over 200 BsIgG toward 4-1BB were generated using an automated purification method we developed that enables milligram-scale production of BsIgG. This approach allowed us to identify antibodies with a wide range of agonistic activity that are being used to further investigate the therapeutic potential of antibodies targeting one or more epitopes of 4-1BB. Taylor & Francis 2017-12-14 /pmc/articles/PMC5825193/ /pubmed/29227213 http://dx.doi.org/10.1080/19420862.2017.1406570 Text en © 2018 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
spellingShingle Report
Van Blarcom, Thomas
Lindquist, Kevin
Melton, Zea
Cheung, Wai Ling
Wagstrom, Chris
McDonough, Dan
Valle Oseguera, Cendy
Ding, Sheng
Rossi, Andrea
Potluri, Shobha
Sundar, Purnima
Pitts, Steven
Sirota, Marina
Galindo Casas, Meri
Yan, Yu
Jones, Jeffrey
Roe-Zurz, Zygy
Srivatsa Srinivasan, Surabhi
Zhai, Wenwu
Pons, Jaume
Rajpal, Arvind
Chaparro-Riggers, Javier
Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
title Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
title_full Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
title_fullStr Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
title_full_unstemmed Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
title_short Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
title_sort productive common light chain libraries yield diverse panels of high affinity bispecific antibodies
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825193/
https://www.ncbi.nlm.nih.gov/pubmed/29227213
http://dx.doi.org/10.1080/19420862.2017.1406570
work_keys_str_mv AT vanblarcomthomas productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT lindquistkevin productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT meltonzea productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT cheungwailing productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT wagstromchris productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT mcdonoughdan productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT valleosegueracendy productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT dingsheng productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT rossiandrea productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT potlurishobha productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT sundarpurnima productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT pittssteven productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT sirotamarina productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT galindocasasmeri productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT yanyu productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT jonesjeffrey productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT roezurzzygy productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT srivatsasrinivasansurabhi productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT zhaiwenwu productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT ponsjaume productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT rajpalarvind productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies
AT chaparroriggersjavier productivecommonlightchainlibrariesyielddiversepanelsofhighaffinitybispecificantibodies